Celularity Inc. - Class A Common Stock (NQ:CELU)

1.600 +0.220 (+15.94%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Celularity Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 16, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

July 16, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 16, 2025

Via Benzinga

Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket ↗

July 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 15, 2025

Via Benzinga

Tuesday's after hours session: top gainers and losers ↗

July 15, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Celularity Inc. Surges Over 8% Pre-Market Amid Florida Stem Cell Policy, New Partnership Boost ↗

July 15, 2025

Celularity Inc. (NASDAQ: CELU) saw an 8.04% rise in stock value during pre-market hours on Tuesday due to a regulatory change.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 13, 2025

Via Benzinga

Which stocks are experiencing notable movement on Wednesday? ↗

March 05, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 07, 2024

Via Benzinga

Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting

June 03, 2024

Company presents results from in vivo studies of PT-CD16VS, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells, in combination with various monoclonal...

From Celularity Inc.

Via GlobeNewswire

Celularity Inc. to Host Investor and Analyst Research & Development Day

April 22, 2024

Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress

From Celularity Inc.

Via GlobeNewswire

Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products

April 15, 2024

From Celularity Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 13, 2024

Via Benzinga

Workday, Domino's And 3 Stocks To Watch Heading Into Monday ↗

February 26, 2024

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 02, 2024

Via Benzinga

Dow Jumps 250 Points; Honeywell Issues Weak Forecast ↗

February 01, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The...

Via Benzinga

Topics Stocks

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 01, 2024

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 01, 2024

Via Benzinga

Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations ↗

February 01, 2024

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 24, 2024

Via Benzinga

Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket ↗

January 22, 2024

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000 ↗

January 18, 2024

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.33% to 37,143.30 while the NASDAQ...

Via Benzinga

Topics Stocks

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 18, 2024

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.